NEW YORK (GenomeWeb) – Flagship Biosciences today said it is collaborating with Advanced Cell Diagnostics for the use of its RNAscope technology. 

Flagship said it is using ACD's technology to support ongoing CLIA-based clinical trials of its clients. Steve Potts, vice president of sales and marketing for Westminster, Colo.-based Flagship, told GenomeWeb in an email that his firm is using RNAscope and customizing and optimizing the technology for use in trials with "several large" undisclosed pharmaceutical clients. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.